Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
A Multiregional Decentralized Clinical Trial Program to Improve Access.
Journal: JAMA network open
Published: June 05, 2026
De-Escalated Adjuvant Radiation Therapy in Patients With HPV-Positive Oropharyngeal Cancer.
Journal: JAMA network open
Published: May 18, 2026
Neoadjuvant Immunotherapy and Chemoimmunotherapy Regimens in Head and Neck Cancer: A Systematic Review and Meta-Analysis.
Journal: JAMA otolaryngology-- head & neck surgery
Published: March 12, 2026
Induction Cisplatin, Docetaxel, and 5-Fluorouracil Versus Platinum Doublet in Human Papillomavirus-Associated Oropharyngeal Cancer.
Journal: Viruses
Published: February 25, 2026
Clinical effectiveness of best-evidence cancer distress management in a real-world practice setting.
Clinical effectiveness of best-evidence cancer distress management in a real-world practice setting.
Journal: Translational behavioral medicine
Published: June 27, 2025
ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal Carcinoma: A Secondary Analysis of the DART Phase 3 Randomized Clinical Trial.
Journal: JAMA otolaryngology-- head & neck surgery
Published: May 22, 2025
Clinical Features, Treatment, and Outcomes for Oropharyngeal Adenoid Cystic Carcinoma: A Systematic Review.
Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Published: May 16, 2025
Postoperative ctHPVDNA Kinetics in Patients With HPV-Related Oropharyngeal Cancer.
Journal: JAMA otolaryngology-- head & neck surgery
Published: May 14, 2025
Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.
Journal: Head & neck
Published: April 25, 2025
De-escalated adjuvant radiotherapy versus standard adjuvant treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma (MC1675): a phase 3, open-label, randomised controlled trial.
Journal: The Lancet. Oncology
Published: March 11, 2025
Assessing the Current Stage of Burnout in Hematology-Oncology Faculty and Trainees- Is There a Path to Remission?
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 08, 2025
NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 12, 2025
Last Updated: 09/26/2026